Literature DB >> 19342615

Role and therapeutic potential of VEGF in the nervous system.

Carmen Ruiz de Almodovar1, Diether Lambrechts, Massimiliano Mazzone, Peter Carmeliet.   

Abstract

The development of the nervous and vascular systems constitutes primary events in the evolution of the animal kingdom; the former provides electrical stimuli and coordination, while the latter supplies oxygen and nutrients. Both systems have more in common than originally anticipated. Perhaps the most striking observation is that angiogenic factors, when deregulated, contribute to various neurological disorders, such as neurodegeneration, and might be useful for the treatment of some of these pathologies. The prototypic example of this cross-talk between nerves and vessels is the vascular endothelial growth factor or VEGF. Although originally described as a key angiogenic factor, it is now well established that VEGF also plays a crucial role in the nervous system. We describe the molecular properties of VEGF and its receptors and review the current knowledge of its different functions and therapeutic potential in the nervous system during development, health, disease and in medicine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342615     DOI: 10.1152/physrev.00031.2008

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  146 in total

1.  Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury.

Authors:  Laura De Laporte; Anne des Rieux; Hannah M Tuinstra; Marina L Zelivyanskaya; Nora M De Clerck; Andrei A Postnov; Véronique Préat; Lonnie D Shea
Journal:  J Biomed Mater Res A       Date:  2011-05-31       Impact factor: 4.396

2.  Evolution of the VEGF-regulated vascular network from a neural guidance system.

Authors:  Sreenivasan Ponnambalam; Mario Alberghina
Journal:  Mol Neurobiol       Date:  2011-01-28       Impact factor: 5.590

Review 3.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

4.  Differentiation state determines neural effects on microvascular endothelial cells.

Authors:  Lara A Muffley; Shin-Chen Pan; Andria N Smith; Maricar Ga; Anne M Hocking; Nicole S Gibran
Journal:  Exp Cell Res       Date:  2012-06-07       Impact factor: 3.905

5.  Multiple neurotrophic effects of VEGF on cultured neurons.

Authors:  Alma Sanchez; Suchin Wadhwani; Paula Grammas
Journal:  Neuropeptides       Date:  2010-04-28       Impact factor: 3.286

Review 6.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

7.  Serum level of vascular endothelial growth factor decreased in chronic ketamine abusers.

Authors:  Ni Fan; Minling Zhang; Ke Xu; Xiaoyin Ke; Yi Ding; Daping Wang; Yuping Liu; Yuping Ning; Xuefeng Deng; Hongbo He
Journal:  Drug Alcohol Depend       Date:  2015-05-08       Impact factor: 4.492

8.  Adult hippocampal neural stem and progenitor cells regulate the neurogenic niche by secreting VEGF.

Authors:  Elizabeth D Kirby; Akela A Kuwahara; Reanna L Messer; Tony Wyss-Coray
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

9.  Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFdelta/delta mouse model of amyotrophic lateral sclerosis.

Authors:  Alice Brockington; Paul R Heath; Hazel Holden; Paul Kasher; Florian L P Bender; Filip Claes; Diether Lambrechts; Michael Sendtner; Peter Carmeliet; Pamela J Shaw
Journal:  BMC Genomics       Date:  2010-03-26       Impact factor: 3.969

10.  CNS-resident progenitors direct the vascularization of neighboring tissues.

Authors:  Ryota L Matsuoka; Andrea Rossi; Oliver A Stone; Didier Y R Stainier
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.